FDA inspection
Chongqing Biocare Pharmaceutical Ltd.: FDA inspection ending Dec 13, 2013
FDA inspection 859052 · No Action Indicated (NAI) · Chongqing
Key facts
| Inspection ID | 859052 |
|---|---|
| Firm | Chongqing Biocare Pharmaceutical Ltd. |
| FEI number | 3006305268 |
| Address | Erlang, Jiulongpo, Kecheng Road; Jiulongpo |
| City | Chongqing |
| Fiscal year | 2014 |
| Inspection end date | Dec 13, 2013 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data